Efficacy and safety of shorter multidrug-resistant or rifampicin-resistant tuberculosis regimens: a network meta-analysis

Abstract Background Drug-resistant tuberculosis (DR-TB) remains a threat to public health. Shorter regimens have been proposed as potentially valuable treatments for multidrug or rifampicin resistant tuberculosis (MDR/RR-TB). We undertook a systematic review and network meta-analysis to evaluate the...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Yishak Abraham, Dawit Getachew Assefa, Tesfahunegn Hailemariam, Desye Gebrie, Dejene Tolossa Debela, Simon Tsegaye Geleta, Dagmawit Tesfaye, Michele Joseph, Tsegahun Manyazewal
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2024-10-01
Serija:	BMC Infectious Diseases
Teme:	Rifampicin-resistant tuberculosis (RR-TB) Multidrug-resistant tuberculosis (MDR-TB) Short- term regimens Systematic review Network meta-analysis
Online dostop:	https://doi.org/10.1186/s12879-024-09960-3
Oznake:	Označite Brez oznak, prvi označite!